CDK4: a master regulator of the cell cycle and its role in cancer-Reference-Cited by-同舟云学术

CDK4: a master regulator of the cell cycle and its role in cancer

Published:2022-08-25 Issue: Volume:13 Page:21-45
ISSN:1947-6027
Container-title:Genes & Cancer
language:en
Short-container-title:Genes Cancer

Author:

Baker Stacey J.¹,Poulikakos Poulikos I.¹²,Irie Hanna Y.¹³,Parekh Samir²³,Reddy E. Premkumar¹⁴

Affiliation:

1. Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, Levy Place, NY 10029, USA

2. Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, Levy Place, NY 10029, USA

3. Department of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, Levy Place, NY 10029, USA

4. Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, Levy Place, NY 10029, USA

Publisher

Impact Journals, LLC

Subject

Cancer Research,Genetics

Reference214 articles.

1. Malumbres M, Barbacid M. Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer. 2009; 9:153–66. https://doi.org/10.1038/nrc2602. [PubMed]

2. Goebl MG, Winey M. The yeast cell cycle. Curr Opin Cell Biol. 1991; 3:242–46. https://doi.org/10.1016/0955-0674(91)90147-q. [PubMed]

3. Morgan DO. Cyclin-dependent kinases: engines, clocks, and microprocessors. Annu Rev Cell Dev Biol. 1997; 13:261–91. https://doi.org/10.1146/annurev.cellbio.13.1.261. [PubMed]

4. Malumbres M, Barbacid M. To cycle or not to cycle: a critical decision in cancer. Nat Rev Cancer. 2001; 1:222–31. https://doi.org/10.1038/35106065. [PubMed]

5. Graña X, Reddy EP. Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene. 1995; 11:211–19. [PubMed]

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Variation of C-terminal domain governs RNA polymerase II genomic locations and alternative splicing in eukaryotic transcription;Nature Communications;2024-09-12

2. Diet-induced Obesity: Pathophysiology, Consequences and Target Specific Therapeutic Strategies;Current Protein & Peptide Science;2024-09-02

3. Exploring Natural Compounds as Potential CDK4 Inhibitors for Therapeutic Intervention in Neurodegenerative Diseases through Computational Analysis;Molecular Biotechnology;2024-08-29

4. Loss of Sirtuin 7 impairs cell motility and proliferation and enhances S-phase cell arrest after 5-fluorouracil treatment in head and neck cancer;2024-08-14

5. AMPK regulates immature boar Sertoli cell proliferation through affecting CDK4/Cyclin D3 pathway and mitochondrial function;Theriogenology;2024-08